• About Amgen
  • Science
  • Corporate Giving
  • Site Map
  • Search
  • Privacy & Terms
  • Contact Us
Amgen
  • Patients
  • Medical Professionals
  • Partners
  • Investors
  • Careers
  • Media
  • print
  • mail
  • Home
  • About Amgen
  • Environmental Sustainability
  • Programs

  • Overview
  • Mission & Values
  • Leadership Team
  • Corporate Governance
  • Corporate Compliance
  • Awards & Recognition
  • Company History
  • Fact Sheets
  • Locations
  • Environmental Sustainability
  • Commitment Statement
  • Programs
  • Compliance
  • Highlights
  • Awards & Recognition
  • Staff Commitment
  • Community Involvement
  • Policies and Practices
Environmental Programs
Water

Water is essential to Amgen manufacturing processes and water is also a limited resource for a number of communities where Amgen operates. As a result, we seek opportunities for water reuse and recycling and we take pride in our successful efforts to use water wisely.

Due to growth and new construction, the water use at our five major U.S. manufacturing, and research and development facilities increased over the last two years. As the table below demonstrates, indexing water usage data to reflect our growth reveals that our water use remained constant.

 

2005

2006

Water Use (MCM)

2.43 2.81

Water Use Indexed to Sales (MCM/$B)

0.20 0.20

MCM/$B = Million Cubic Meters/$Billion sales. 
Indexed to reflect company growth.


Environmental Highlight: Click here to read how Amgen facilities in Rhode Island and Puerto Rico reduced their dependence on local water supplies while operating more efficiently.

Successful water management means not only reducing water use but also monitoring wastewater discharge. To comply with local wastewater requirements, each Amgen facility operates under agreements that regulate the amount and type of materials discharged in wastewater, and adheres to all reporting requirements.

To better manage wastewater in the future, we initiated a Global Wastewater Study. The Study created detailed facility plans that address wastewater discharge at our major facilities and ensure adequate capacity for growth. The plans led to capital projects to improve the treatment and discharge of wastewater at most of the major sites.

Pictured: A wastewater plant at Amgen Manufacturing Limited, Puerto Rico became operational in 2006. The plant design was based on recommendations in Amgen’s comprehensive Global Wastewater Study.

Energy

Energy conservation and the reduction of greenhouse gases, such as carbon dioxide (CO2), are an important part of Amgen’s commitment to sustainable operations. Facing the future challenges brought about by both global warming and the finite reserves of fossil fuels will require a global effort involving many industries. For its part, Amgen has implemented many energy-saving programs and continues to search out new ways to reduce our energy usage.

 

2005

2006

Direct Energy Use (GJ)

1,777,794 1,890,821

Indirect Energy Use (GJ)

1,666,473

1,776,414

Direct Energy Use
Indexed to Sales (GJ/$B)

147,878

136,442

Indirect Energy Use
Indexed to Sales (GJ/$B)

138,619

128,187

GJ/$B = Gigajoules/$Billion sales.
Indexed to reflect company growth.
Direct Energy results from on-site combustion of natural gas and diesel; Indirect Energy results from the purchase of electricity.

We are collecting data on the generation of CO2 from our five major U.S. manufacturing, and research and development facilities. At the same time, we are exploring opportunities to reduce the amount of CO2 we generate, including purchasing renewable energy.

 

2005

2006

CO2 from Direct Energy (MT)

93,867

100,986

CO2  from Indirect Energy (MT)

245,089

273,927

CO2  from Direct Energy Indexed to
Energy Consumed (MT/GJ Energy Consumed)

0.053

0.053

CO2  from Indirect Energy Indexed to
Energy Consumed (MT/GJ Energy Consumed)

0.152

0.154

MT/GJ Energy Consumed = Metric Tons/Gigajoules
of Energy Consumed.

Amgen participates in the Carbon Disclosure Project (CDP). For more information on the CDP please click here.


Waste

Pollution prevention is another critical element of Amgen’s commitment to environmental sustainability. We use pollution prevention teams, process changes and staff training programs to reduce, reuse or recycle the waste materials that we generate.

We track the amount of hazardous waste generated at each of our five major U.S. manufacturing, and research and development facilities. Each site looks for and implements opportunities to prevent pollution and minimize waste.

Not only are we working to reduce the amount of hazardous waste we generate, we have a system in place to ensure that it is properly disposed of at facilities that operate responsibly. Hazardous waste treatment and disposal facilities used by Amgen undergo initial as well as ongoing audits to ensure their performance meets our standards. 

 

2005

2006

Hazardous Waste (MT)

1,043

915

Hazardous Waste Indexed to Sales
(Metric Tons/$B)

87

66

MT/$B = Metric Tons/$Billion sales. Indexed to reflect company growth. Hazardous waste includes Resource Conservation and Recovery Act (RCRA), State Hazardous, Universal, and Radioactive waste.


Environmental Highlight: Click here to see how Amgen is reducing the amount of hazardous waste generated in its laboratories.

Amgen strives to reduce the impact of waste on the local communities that host our facilities. Many Amgen sites have recycling programs in place and encourage staff involvement through educational activities such as our annual Earth Day events. In addition, our facility in Thousand Oaks, California, has equipment adoption programs in place that benefit local schools and other nonprofit organizations.

Environmental Highlight: Click here to read about Amgen’s award-winning waste reduction programs.


  • Related Links
  • Amgen Overview
  • Values
  • Press Releases
  • Diversity
  • Corporate Compliance
  • Locations
  • Contact Us
footer